Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month efficacy and tolerability, multicenter, open-label prospective study

By Rossi Gemma Caterina Maria   Tinelli Carmine   Pasinetti Gian Maria   Fusetti Marina   Pallavicini Claudio   Stringa Massimo   Vacchi Sauro   Stringa Francesco   Bianchi Paolo Emilio  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 5, 2011-04 ,pp. : 685-690

Informa Healthcare

Access to resources Recommend Favorite

The fixed combinations brimonidine/timolol and dorzolamide/timolol have "similar" efficacy in patients with glaucoma or ocular hypertension

By  

Inpharma, Vol. 1, Iss. 1589, 2007-01 ,pp. : 18-19

Adis International

Access to resources Recommend Favorite

Ocular Carteolol: A Review of its Use in the Management of Glaucoma and Ocular Hypertension

By Henness Sheridan   Tracy Swainston Harrison   Keating Gillian M.  

Drugs & Aging, Vol. 24, Iss. 6, 2007-01 ,pp. : 509-528

Adis International

Access to resources Recommend Favorite

Brinzolamide/Timolol: In Open-Angle Glaucoma and Ocular Hypertension

By Croxtall Jamie D.   Scott Lesley J.  

Drugs & Aging, Vol. 26, Iss. 5, 2009-05 ,pp. : 437-446

Adis International

Access to resources Recommend Favorite

Latanoprost: An Update of its Use in Glaucoma and Ocular Hypertension

By Perry C.M.   McGavin J.K.   Culy C.R.   Ibbotson T.  

Drugs & Aging, Vol. 20, Iss. 8, 2003-01 ,pp. : 597-630

Adis International

Access to resources Recommend Favorite